CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN DIABETIC PATIENTS

ccording to recent reports, the most common cause of chronic renal failure (CRF) is diabetic nephropathy. United States Renal Data System (USRDS) showed that in 1989, 3 % of all new CRF patients accepted for renal replacement therapy (RRT) were diabetic. This ratio has been increasing from 3 % to 35 % since 1989. Renal replacement therapy modalities such as renal - renal & pancreas transplantation, hemodialysis and continuous peritoneal dialysis are recommended for end-stage diabetic nephropathy patients. In recent years, Continuous Ambulatory Peritoneal Dialysis (CAPD) is the first choice of RRT for these patients as the control of hypertension and hyperglicemia and preservation of residual renal functions are excellent. In this lecture, CAPD in diabetics was rewieved.